{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:41:54Z","timestamp":1793014914592,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Boswellin\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Super is a standardized extract of\n                      <jats:italic>Boswellia serrata<\/jats:italic>\n                      Roxb gum resin, standardized to contain 30% 3-acetyl-11-keto-\u03b2-boswellic acid along with other \u03b2-boswellic acids (BSE). A randomized, double-blind, placebo-controlled clinical trial was conducted at two doses of BSE to understand its safety and efficacy in supporting joint health and improving mobility and symptoms of osteoarthritis (OA) of the knee.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Based on the inclusion\/exclusion criteria, 105 newly diagnosed participants with degenerative hypertrophy OA were recruited and randomized into Placebo, BSE-150\u00a0mg or BSE-300\u00a0mg (n = 35 in each group) to receive either 150\u00a0mg or 300\u00a0mg BSE or a placebo tablet twice a day for 90\u00a0days. All the participants were evaluated for pain and physical function using the standard tools including the Visual Analog Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Lequesne Functional Index (LFI), EuroQol- 5 Dimension (EQ-5D) quality of life, 6-min walk test at day 0, days 5, 30, 60 and 90 of treatment. Additionally, the circulating levels of inflammatory biomarkers, tumor necrosis factor-\u03b1 (TNF\u03b1), high-sensitive C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were evaluated. Safety was evaluated by blood biochemical, hematological analysis, urinary analyses and by monitoring adverse events throughout the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety-eight subjects completed the study. Improvements in pain scores were observed as early as 5\u00a0days after the start of the supplement in the BSE-150 and BSE-300 groups. By 90\u00a0days, the VAS pain score reduced by 45.3% and 61.9%, WOMAC- total score improved by 68.5% and 73.6% in the BSE-150 and BSE-300 groups respectively. WOMAC pain (70.2%, 73.9%, WOMAC stiffness (65.6%,68.9%), WOMAC function (68.8%,74.2%), LFI severity (50%,53.3%), decreased and EQ5D (56.9%, 62.9%) and distance walked in 6\u00a0minutes (21.2%, 21.9%) improved in the BSE-150 and BSE-300 groups in 90 days. Further, the levels of TNF\u03b1, hs-CRP, and IL-6 were found to decrease in the serum in BSE-supplemented participants. No significant adverse events were recorded during the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The study confirms that\n                      <jats:bold>Boswellin\u00ae Super<\/jats:bold>\n                      can be used as a safe and effective supplement to support joint health and mobility in the management of osteoarthritis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration:<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=NzU2Nzc=&amp;amp;Enc=&amp;amp;userName=CTRI<\/jats:ext-link>\n                      , identifier CTRI\/2022\/11\/047397\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1428440","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T01:10:55Z","timestamp":1721265055000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial"],"prefix":"10.3389","volume":"15","author":[{"given":"Anju","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheen","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Manjunatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikh Nawazish","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelanagowda V. P.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Mundkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"B1","first-page":"379","article-title":"Antitumor efficacy of Boswellia serrata extract in management of colon cancer induced in experimental animal","volume":"5","author":"Ahmed","year":"2013","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18231\/j.ijcap.2021.014","article-title":"A comparison of pain and disability scores in different grades of knee OA before and after low level laser therapy (LLLT)","volume":"8","author":"Arun Kumar M","year":"2021","journal-title":"Indian J. Clin. Anat. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4081\/monaldi.2012.121","article-title":"EuroQol-5D (EQ-5D): an instrument for measuring quality of life","volume":"78","author":"Balestroni","year":"2012","journal-title":"Monaldi Arch. Chest Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/j157v04n03_06","article-title":"Boswellia: an evidence-based systematic review by the natural standard research collaboration","volume":"4","author":"Basch","year":"2004","journal-title":"J. Herb. Pharmacother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/s1570-0232(03)00160-0","article-title":"Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high-performance liquid chromatography. Identification of lupeolic acid, a novel pentacyclic triterpene","volume":"791","author":"B\u00fcchele","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0033-8389(03)00161-1","article-title":"An update on the pathogenesis and epidemiology of osteoarthritis","volume":"42","author":"Felson","year":"2004","journal-title":"Radiol. Clin. North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/BOR.0b013e328349c2b1","article-title":"Inflammation in osteoarthritis","volume":"23","author":"Goldring","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/0974-8520.96119","article-title":"Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis)","volume":"32","author":"Gupta","year":"2011","journal-title":"Ayu"},{"key":"B11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18433\/j3vw2f","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1078\/094471103321648593","article-title":"Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial","volume":"10","author":"Kimmatkar","year":"2003","journal-title":"Phytomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1007\/s11999-016-4732-4","article-title":"Classifications in brief: kellgren-Lawrence Classification of osteoarthritis","volume":"474","author":"Kohn","year":"2016","journal-title":"Clin. Orthop. Relat. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/aje\/152.9.855","article-title":"Factors associated with osteoarthritis of the hip and knee in Hong Kong Chinese: obesity, joint injury, and occupational activities","volume":"152","author":"Lau","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"B15","first-page":"779","article-title":"The algofunctional indices for hip and knee osteoarthritis","volume":"24","author":"Lequesne","year":"1997","journal-title":"J. Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/ptr.6338","article-title":"A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee","volume":"33","author":"Majeed","year":"2019","journal-title":"Phytother. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"735247","DOI":"10.3389\/fphys.2021.735247","article-title":"Boswellia serrata extract containing 30% 3-acetyl-11-keto-boswellic acid attenuates inflammatory mediators and preserves extracellular matrix in collagen-induced arthritis","volume":"12","author":"Majeed","year":"2021","journal-title":"Front. Physiology"},{"key":"B18","volume-title":"Boswellin\u00ae anti-inflammatory adaptogen from nature","author":"Majeed","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.22259\/ijrsmhs.0507005","article-title":"Mutagenic, genotoxic and sub chronic oral safety analysis of Boswellia serrata extract (Boswellin\u00aeSuper)","volume":"5","author":"Majeed","year":"","journal-title":"Int. J. Res. Stud. Med. Health Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/bja\/aew466","article-title":"Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state","volume":"118","author":"Myles","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2174\/092986706779010333","article-title":"Boswellic acids: biological actions and molecular targets","volume":"13","author":"Poeckel","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1089\/ars.2006.8.653","article-title":"Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia","volume":"8","author":"Roy","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/dna.2005.24.244","article-title":"Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells","volume":"24","author":"Roy","year":"2005","journal-title":"DNA Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1476-5381.1996.tb15235.x","article-title":"Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity","volume":"117","author":"Sailer","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1021\/np000069k","article-title":"Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues","volume":"63","author":"Schweizer","year":"2000","journal-title":"J. Nat. Prod."},{"key":"B26","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/ar2461","article-title":"A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee","volume":"10","author":"Sengupta","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.7150\/ijms.7.366","article-title":"Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study","volume":"7","author":"Sengupta","year":"2010","journal-title":"Int. J. Med. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"31s","DOI":"10.1016\/s0002-9343(98)00072-2","article-title":"Recent considerations in nonsteroidal anti-inflammatory drug gastropathy","volume":"105","author":"Singh","year":"1998","journal-title":"Am. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjsports-2019-100959","article-title":"Risk of knee osteoarthritis after different types of knee injuries in young adults: a population-based cohort study","volume":"54","author":"Snoeker","year":"2020","journal-title":"Br. J. Sports Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0253-7613.30759","article-title":"Open, Randomized, Controlled Clinical Trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee","volume":"39","author":"Sontakke","year":"2007","journal-title":"Indian J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4049\/jimmunol.174.1.498","article-title":"Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases","volume":"174","author":"Syrovets","year":"2005","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"Jama"},{"key":"B33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.7150\/ijms.8.615","article-title":"A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee","volume":"8","author":"Vishal","year":"2011","journal-title":"Int. J. Med. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"The Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2288-5-26","article-title":"The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials--a secondary analysis","volume":"5","author":"Walach","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"B37","first-page":"1131","article-title":"The double-edged sword of COX-2 selective NSAIDs","volume":"167","author":"Wright","year":"2002","journal-title":"Cmaj"},{"key":"B38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12906-020-02985-6","article-title":"Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis","volume":"20","author":"Yu","year":"2020","journal-title":"BMC Complement. Med. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1428440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T01:11:00Z","timestamp":1721265060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1428440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":38,"alternative-id":["10.3389\/fphar.2024.1428440"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1428440","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"article-number":"1428440"}}